Product introduce: 3-morpholino-1-(4-nitrophenyl)-5,6-dihydropyridin-2 (1h)-one is a pharmaceutical intermediate used as an apixabn intermediate. Apixs is an antithrombotic drug, which is a direct inhibitor of factor Xa jointly developed by Bristol-Myers Squibb and Pfizer. It was approved for marketing in the EU in March 2011, and was approved for marketing in the United States by the FDA in December 2012.